International Immunopharmacology, Год журнала: 2024, Номер 146, С. 113917 - 113917
Опубликована: Дек. 24, 2024
Язык: Английский
International Immunopharmacology, Год журнала: 2024, Номер 146, С. 113917 - 113917
Опубликована: Дек. 24, 2024
Язык: Английский
Cell Communication and Signaling, Год журнала: 2024, Номер 22(1)
Опубликована: Апрель 2, 2024
Abstract Lung cancer is a deeply malignant tumor with high incidence and mortality. Despite the rapid development of diagnosis treatment technology, abundant patients lung are still inevitably faced recurrence metastasis, contributing to death. Lymphatic metastasis first step distant an important prognostic indicator non-small cell cancer. Tumor-induced lymphangiogenesis involved in construction microenvironment, except promoting proliferation cells, it also plays crucial role individual response treatment, especially immunotherapy. Thus, this article reviews current research status lymphatic cancer, order provide some insights for basic clinical translational application field.
Язык: Английский
Процитировано
4International Immunopharmacology, Год журнала: 2024, Номер 146, С. 113917 - 113917
Опубликована: Дек. 24, 2024
Язык: Английский
Процитировано
0